Skip to main content
. 2020 Mar 5;10:4112. doi: 10.1038/s41598-020-60952-0

Figure 1.

Figure 1

Growth curves of cannabidiol (CBD) in combination with bacitracin (BAC). Bacterial density (BCA: Background corrected absorption) was measured using an oCelloScope for 24 hours; (a) Methicillin-resistant Staphylococcus aureus USA300 FPR 3757, (b) Enterococcus faecalis (13-327129), (c) Listeria monocytogenes EGD, (d) Methicillin-resistant Staphylococcus epidermidis. (e) Time-kill assay showing the effect of CBD and BAC in monotherapy and combination in MRSA USA300 FPR3757. Viability was monitored by OD600 readings and CFU/mL determinations. Growth experiments were repeated at least three times and the time-kill assay was repeated twice with similar results.